- Home
- LIDR vs CHRO Comparison
LIDR vs CHRO Comparison
Compare LIDR & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIDR
- CHRO
- Stock Information
- Founded
- LIDR 2013
- CHRO 2002
- Country
- LIDR United States
- CHRO United States
- Employees
- LIDR N/A
- CHRO N/A
- Industry
- LIDR Auto Parts:O.E.M.
- CHRO
- Sector
- LIDR Consumer Discretionary
- CHRO
- Exchange
- LIDR Nasdaq
- CHRO Nasdaq
- Market Cap
- LIDR 9.8M
- CHRO 10.7M
- IPO Year
- LIDR N/A
- CHRO 2024
- Fundamental
- Price
- LIDR $0.59
- CHRO $1.45
- Analyst Decision
- LIDR Hold
- CHRO Strong Buy
- Analyst Count
- LIDR 1
- CHRO 1
- Target Price
- LIDR N/A
- CHRO N/A
- AVG Volume (30 Days)
- LIDR 307.0K
- CHRO 8.2K
- Earning Date
- LIDR 05-13-2025
- CHRO 03-27-2025
- Dividend Yield
- LIDR N/A
- CHRO N/A
- EPS Growth
- LIDR N/A
- CHRO N/A
- EPS
- LIDR N/A
- CHRO N/A
- Revenue
- LIDR $202,000.00
- CHRO N/A
- Revenue This Year
- LIDR $2,677.23
- CHRO N/A
- Revenue Next Year
- LIDR $409.09
- CHRO N/A
- P/E Ratio
- LIDR N/A
- CHRO N/A
- Revenue Growth
- LIDR N/A
- CHRO N/A
- 52 Week Low
- LIDR $0.51
- CHRO $0.45
- 52 Week High
- LIDR $5.15
- CHRO $3.80
- Technical
- Relative Strength Index (RSI)
- LIDR 41.30
- CHRO 43.38
- Support Level
- LIDR $0.55
- CHRO $1.34
- Resistance Level
- LIDR $0.68
- CHRO $2.00
- Average True Range (ATR)
- LIDR 0.06
- CHRO 0.17
- MACD
- LIDR 0.01
- CHRO -0.02
- Stochastic Oscillator
- LIDR 28.83
- CHRO 16.58
About LIDR AEye Inc.
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.